首页> Journal of nuclear medicine : official publication, Society of Nuclear Medicine> Signaling Network Response to α-Particle-Targeted Therapy with the 225Ac-Labeled Minigastrin Analog 225Ac-PP-F11N Reveals the Radiosensitizing Potential of Histone Deacetylase Inhibitors.

Signaling Network Response to α-Particle-Targeted Therapy with the 225Ac-Labeled Minigastrin Analog 225Ac-PP-F11N Reveals the Radiosensitizing Potential of Histone Deacetylase Inhibitors.

导出 OA

翻译打印收藏纠错

第一作者： Yun,Qin

第一单位： Center for Radiopharmaceutical Sciences, Paul Scherrer Institute, Villigen, Switzerland.;Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.

作者： Yun,Qin ^[1] ; Stefan,Imobersteg ^[2] ; Stephan,Frank ^[3] ; Alain,Blanc ^[2] ; Tanja,Chiorazzo ^[2] ; Philipp,Berger ^[4] ; Roger,Schibli ^[1] ; Martin P,Béhé ^[5] ; Michal,Grzmil ^[5]

作者单位： Center for Radiopharmaceutical Sciences, Paul Scherrer Institute, Villigen, Switzerland.;Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland. ^[1] Center for Radiopharmaceutical Sciences, Paul Scherrer Institute, Villigen, Switzerland. ^[2] Division of Neuropathology, Institute of Pathology, University of Basel, Basel, Switzerland; and. ^[3] Laboratory of Nanoscale Biology, Paul Scherrer Institute, Villigen, Switzerland. ^[4] Center for Radiopharmaceutical Sciences, Paul Scherrer Institute, Villigen, Switzerland; martin.behe@psi.ch michal.grzmil@psi.ch. ^[5]

关键词 225Ac CCKBR minigastrin phosphoproteomics radioresistance